These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 1300702)
1. [Changes in the cytostatic and cytotoxic activities of the peripheral blood lymphocytes in the surgical treatment of lung cancer patients]. Polushina OA; Lian NV; Bogdashin IV Vopr Onkol; 1992; 38(2):173-7. PubMed ID: 1300702 [TBL] [Abstract][Full Text] [Related]
2. [The response of peripheral blood lymphocytes from lung cancer patients to in-vitro treatment with recombinant interleukin-2]. Pogodina ON; Karaseva NA; Ivanov VA Tsitologiia; 1997; 39(7):582-9. PubMed ID: 9490499 [TBL] [Abstract][Full Text] [Related]
3. [Changes in hormonal-mediatory and immunological indices during anesthesia in cancer patients]. Lian NV; Vasil'ev NV; Smol'ianinov ES; Kuznetsov VV Vopr Onkol; 1986; 32(10):54-8. PubMed ID: 2877523 [TBL] [Abstract][Full Text] [Related]
4. Natural cytotoxicity of peripheral blood lymphocytes and regional lymph node cells in breast cancer in women. Cunningham-Rundles S; Filippa DA; Braun DW; Antonelli P; Ashikari H J Natl Cancer Inst; 1981 Sep; 67(3):585-90. PubMed ID: 6944530 [TBL] [Abstract][Full Text] [Related]
5. The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients. Konishi J; Yamazaki K; Yokouchi H; Shinagawa N; Iwabuchi K; Nishimura M Hum Immunol; 2004 Nov; 65(11):1377-88. PubMed ID: 15556688 [TBL] [Abstract][Full Text] [Related]
6. [Effect of surgical treatment on the natural killer activity in lung cancer patients]. Ancheva M; Boeva M; Tenev V Eksp Onkol; 1989; 11(2):39-41. PubMed ID: 2737129 [TBL] [Abstract][Full Text] [Related]
7. [Specific antitumor cytotoxicity of blood platelets from the peripheral blood of patients with lung cancer]. Bykovskaia SN; Blokhina NG; Speranskiĭ DL; Kuprianova TA Biull Eksp Biol Med; 1988 Jun; 105(6):708-9. PubMed ID: 3390590 [TBL] [Abstract][Full Text] [Related]
8. [Cytolytic activity of mononuclear cells, T-lymphocytes and monocytes of the peripheral blood in patients with lung cancer]. Speranskiĭ DL; Blokhina NG; Bykovskaia SN; Kupriianova TA Biull Eksp Biol Med; 1988 Jul; 106(7):68-70. PubMed ID: 3261176 [TBL] [Abstract][Full Text] [Related]
9. [Natural killer activity and sensitization of the lymphocytes to tissue antigens in lung cancer]. Red'ko AA; Malygin AM; Dvaladze NA; Pleskach VA; Kutushev FKh Vestn Khir Im I I Grek; 1988 Feb; 140(2):12-5. PubMed ID: 3388698 [TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity tests against cultured human lung cancer cells with autologous lymphocytes activated in vitro by mitomycin C-treated tumor monolayers in the presence of T-cell growth factor. Kimura H; Yamaguchi Y; Kadoyama C; Sato N; Fujisawa T Jpn J Clin Oncol; 1983 Mar; 13(1):3-13. PubMed ID: 6300483 [TBL] [Abstract][Full Text] [Related]
11. [Effect of different types of interferon on the natural cellular cytotoxicity of lung cancer patients]. Avdeev GI; Viadro MM; Leĭkin IuD; Kuznetsov VP; Trakhtenberg AKh Eksp Onkol; 1986; 8(3):44-6. PubMed ID: 2424715 [TBL] [Abstract][Full Text] [Related]
12. Natural cytotoxicity in humans: susceptibility of freshly isolatd tumor cells to lysis. Vose BM; Moore M J Natl Cancer Inst; 1980 Aug; 65(2):257-63. PubMed ID: 6157044 [TBL] [Abstract][Full Text] [Related]
13. [Natural antitumor cytotoxicity of the whole blood of donors and cancer patients]. Balashov KE; Letiagin VP; Ozherel'ev AS; Oleĭnikova OM; Kadagidze ZG Vopr Onkol; 1987; 33(12):71-4. PubMed ID: 3424710 [TBL] [Abstract][Full Text] [Related]
14. [The count of the large granule-containing lymphocytes of the peripheral blood and the natural killer activity in patients with malignant tumors]. Kindzel'skiĭ LP; Zlochevskaia LL; Tsyganok TV; Shabaeva MM; Zhukova MM; Rudaia OI Vrach Delo; 1990 Aug; (8):31-2. PubMed ID: 2256279 [TBL] [Abstract][Full Text] [Related]
15. Cytotoxic activity of various LAK cells against autologous lung cancer, K-562 and Daudi cells. Kimura H; Yamaguchi Y Jpn J Clin Oncol; 1989 Sep; 19(3):222-8. PubMed ID: 2810822 [TBL] [Abstract][Full Text] [Related]
16. Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes. Peters PM; Ortaldo JR; Shalaby MR; Svedersky LP; Nedwin GE; Bringman TS; Hass PE; Aggarwal BB; Herberman RB; Goeddel DV J Immunol; 1986 Oct; 137(8):2592-8. PubMed ID: 3760569 [TBL] [Abstract][Full Text] [Related]
17. [Clinical features and inhibitory activity of regional lymph node cells on the cytotoxicity of autologous killer cells in patients with primary lung cancer]. Kadoyama C; Kimura H; Yamaguchi Y Gan To Kagaku Ryoho; 1987 Oct; 14(10):2906-11. PubMed ID: 2959205 [TBL] [Abstract][Full Text] [Related]
18. Autologous tumor killing activity as a prognostic factor in primary resected nonsmall cell carcinoma of the lung. Fujisawa T; Yamaguchi Y Cancer; 1997 Feb; 79(3):474-81. PubMed ID: 9028357 [TBL] [Abstract][Full Text] [Related]